학술논문
Long-term outcomes in patients with PET-predicted poor-responsive HER2-positive breast cancer treated with neoadjuvant bevacizumab added to trastuzumab and docetaxel: 5-year follow-up of the randomised Avataxher study
Document Type
Article
Author
Coudert, Bruno; Pierga, Jean-Yves; Mouret-Reynier, Marie-Ange; Kerrou, Kaldoun; Ferrero, Jean-Marc; Petit, Thierry; Du, Fanny Le; Dupré, Pierre-François; Bachelot, Thomas; Gabelle, Philippe; Chauvet, Marie-Pierre; Coeffic, David; Barbe, Catherine; Prevost, Jean-Briac; Paintaud, Gilles; Thibault, Gilles; Ferhat, Abdennour; Dupin, Julien; Berriolo-Riedinger, Alina; Arnould, Laurent
Source
In EClinicalMedicine November 2020 28
Subject
Language
ISSN
2589-5370